Company intelligence / Profile preview

Oriento

Lugano, Ticino, Switzerlandoriento.fi ↗

Ownership: Private
Development stage: Other

Overview

Oriento SA is an active Swiss-based life sciences consultancy specializing in process development and GMP manufacturing support for biologics, bioconjugates, nanodrugs, and small molecules. The company offers custom advisory services to pharmaceutical companies with a focus on CDMO selection, CMC support for drug substances, particle engineering (including spray drying and micronization), solid-state analysis/polymorphism of small molecules, supply chain logistics advice, and knowledge management.

Modalities: Small moleculeBiologicBioconjugateNanodrug (advisory/support, not direct development)
Industry: Consulting

Beyond the preview

Go deeper on Oriento.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oriento.

Explore the full profile